After Neuralink, Max Hodak is building something stranger

Max Hodak, the co-founder and CEO of Science Corp., is drawing attention as he embarks on a groundbreaking journey in brain-computer interface (BCI) technology that could redefine human potential. Reflecting on his past experiences with Elon Musk at Neuralink, Hodak speaks with a casual confidence about tackling the complexities of cognitive enhancement. Hodak began his programming career at the age of six and later worked with renowned neuroscientist Miguel Nicolelis during his time at Duke University. He co-founded Neuralink in 2016, where he played a pivotal role in its daily operations until 2021. When recalling his time with Musk, Hodak notes how they often faced challenging decisions together, with Musk's decisiveness shaping their approach to problem-solving. Four years ago, Hodak leveraged his Neuralink experience to establish Science Corp. He envisions a future where the boundaries of cognition are pushed further than ever before. The landscape of BCI technology is rapidly evolving, with nearly 700 companies involved globally, including tech giants like Microsoft and Apple, who are exploring innovative applications of this technology. One of Science Corp.'s most promising projects is Prima, a miniature chip implanted in the retina that restores vision for people suffering from advanced macular degeneration. This device, which works in conjunction with specially designed glasses, has shown remarkable results in clinical trials, enabling 80% of participants to regain the ability to read. With plans to launch in Europe next summer, Science Corp. is positioning itself on the cusp of a significant medical breakthrough. Looking ahead, Hodak's ambitions extend into gene therapy, which aims to make neurons responsive to light rather than relying on external electrodes. This innovative approach could potentially transform how we address vision loss. While many companies explore similar avenues, Hodak believes that Science Corp.'s methods are uniquely effective, utilizing advanced proteins for enhanced sensitivity and speed. Yet, Hodak’s vision does not stop at restoring sight. He dreams of creating new brain tissue, addressing the limitations of current BCI technologies that often cause damage to existing neurons. His team has developed a proof-of-concept device tested in mice, which promotes neural growth in a biocompatible manner. This could pave the way for future applications that enhance cognitive function and potentially even consciousness itself. In a thought-provoking twist, Hodak proposes that BCI technology might one day facilitate a collective consciousness, enabling interconnected minds to share experiences and knowledge in unprecedented ways. While this notion may sound sci-fi, Hodak presents it with a sense of urgency, suggesting that as technological advancements unfold, the implications for society could be profound. As Science Corp. continues to innovate, Hodak acknowledges the challenges that come with rapid advancements in health technology. He raises concerns about access and equity in healthcare as BCI treatments become available. The potential for creating a divide based on cognitive enhancements looms large, with the possibility that only the affluent may access these cutting-edge technologies. In the coming years, Hodak envisions a world where individuals facing terminal illnesses could choose to preserve their consciousness through BCI. This prospect raises ethical questions about identity and the essence of being human. As he reflects on these possibilities, it’s clear that Hodak is not just building technology; he is navigating the very fabric of human existence and its future. With timelines set for 2035 and beyond, Hodak’s vision for Science Corp. could reshape our understanding of health and consciousness, potentially altering the trajectory of human evolution itself. As we stand on the brink of these advancements, the dialogue surrounding the implications of BCI technology continues to evolve, leaving us to ponder the future of humanity in a world where the lines between man and machine blur.